SK285796B6 - Farmaceutický prípravok na báze erytropoietínu a železa vo forme fyziologicky prijateľných zlúčenínželeza - Google Patents

Farmaceutický prípravok na báze erytropoietínu a železa vo forme fyziologicky prijateľných zlúčenínželeza Download PDF

Info

Publication number: SK285796B6
Authority: SK; Slovakia
Prior art keywords: iron; erythropoietin; units; preparation; treatment
Prior art date: 1995-09-14

Application number

SK327-98A

Other languages

English (en)

Slovak (sk)

Other versions

SK32798A3 (en

Inventor

Paul Lehmann

Original Assignee

Roche Diagnostics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-14

Filing date

1996-09-12

Publication date

2007-08-02

1996-09-12 Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh

1999-03-12 Publication of SK32798A3 publication Critical patent/SK32798A3/sk

2007-08-02 Publication of SK285796B6 publication Critical patent/SK285796B6/sk

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicinal Preparation (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SK327-98A 1995-09-14 1996-09-12 Farmaceutický prípravok na báze erytropoietínu a železa vo forme fyziologicky prijateľných zlúčenínželeza SK285796B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19535571A DE19535571A1 (de)	1995-09-14	1995-09-14	Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
PCT/EP1996/003997 WO1997009996A1 (de)	1995-09-14	1996-09-12	Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (2)

Publication Number	Publication Date
SK32798A3 SK32798A3 (en)	1999-03-12
SK285796B6 true SK285796B6 (sk)	2007-08-02

Family

ID=7773098

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK327-98A SK285796B6 (sk)	1995-09-14	1996-09-12	Farmaceutický prípravok na báze erytropoietínu a železa vo forme fyziologicky prijateľných zlúčenínželeza

Country Status (26)

Country	Link
US (2)	US6333306B1 (et)
EP (1)	EP0851762B1 (et)
JP (1)	JP4783482B2 (et)
KR (1)	KR100350761B1 (et)
CN (1)	CN1133463C (et)
AT (1)	ATE216256T1 (et)
AU (1)	AU724623B2 (et)
BR (1)	BR9609971A (et)
CA (1)	CA2231192C (et)
CZ (1)	CZ291427B6 (et)
DE (3)	DE19535571A1 (et)
DK (1)	DK0851762T3 (et)
EE (1)	EE03856B1 (et)
ES (1)	ES2174107T3 (et)
HU (1)	HU225363B1 (et)
IL (2)	IL123640A0 (et)
MX (1)	MX9801922A (et)
NO (1)	NO329908B1 (et)
NZ (1)	NZ319132A (et)
PL (1)	PL186776B1 (et)
PT (1)	PT851762E (et)
SK (1)	SK285796B6 (et)
TR (1)	TR199800472T1 (et)
UA (1)	UA57713C2 (et)
WO (1)	WO1997009996A1 (et)
ZA (1)	ZA967732B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000514092A (ja) *	1997-03-18	2000-10-24	ロシュダイアグノスティクスゲゼルシャフトミットベシュレンクテルハフツング	エリトロポエチン及び鉄調製物を含む医薬的組み合わせ調製物
EP0885613A1 (de) *	1997-06-21	1998-12-23	Roche Diagnostics GmbH	Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) *	1997-08-08	1999-02-11	Boehringer Mannheim Gmbh	Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
EP1813624B1 (en) *	1998-10-23	2010-08-11	Amgen Inc.	Methods and compositions for the prevention and treatment of anemia
US7304150B1 (en)	1998-10-23	2007-12-04	Amgen Inc.	Methods and compositions for the prevention and treatment of anemia
CN100528235C (zh)	2000-12-20	2009-08-19	霍夫曼-拉罗奇有限公司	红细胞生成素共轭物
EP1909106B1 (en) *	2001-09-14	2013-01-02	F. Hoffmann-La Roche AG	Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US6930086B2 (en)	2001-09-25	2005-08-16	Hoffmann-La Roche Inc.	Diglycosylated erythropoietin
US7300915B2 (en) *	2002-06-05	2007-11-27	The Regents Of The University Of California	Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US7459435B2 (en) *	2002-08-29	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
US7459436B2 (en) *	2002-11-22	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
US7964568B2 (en) *	2003-05-30	2011-06-21	Chromaceutical Advanced Technologies, Inc.	Synthesis of high molecular weight iron-saccharidic complexes
US7772182B2 (en) *	2004-08-05	2010-08-10	Alza Corporation	Stable suspension formulations of erythropoietin receptor agonists
US7586589B2 (en) *	2005-09-24	2009-09-08	Beckman Coulter, Inc.	Methods of determination of responsiveness to erythropoietin treatment
DK2054074T3 (da)	2006-08-04	2014-11-03	Prolong Pharmaceuticals Llc	Modificeret erythropoietin
CL2008002054A1 (es)	2007-07-17	2009-05-29	Hoffmann La Roche	Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
AR067537A1 (es)	2007-07-17	2009-10-14	Hoffmann La Roche	Purificacion de polipeptidos pegilados
ES2974273T3 (es)	2013-06-13	2024-06-26	Akebia Therapeutics Inc	Composiciones y métodos para tratar la anemia
PT3380487T (pt)	2015-11-23	2020-10-29	Bristol Myers Squibb Co	Sistemas de aditivos para utilização na peguilação de proteínas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6039681B2 (ja) *	1976-01-01	1985-09-07	日本臓器製薬株式会社	デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
IL77081A (en)	1984-12-04	1999-10-28	Genetics Inst	AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US4745099A (en) *	1985-02-06	1988-05-17	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of malignant tumors
JPS6231A (ja) *	1985-02-06	1987-01-06	Chugai Pharmaceut Co Ltd	腎性貧血治療剤
JP2858752B2 (ja) *	1987-04-10	1999-02-17	オーソ・フアーマシユーチカル・コーポレーシヨン	正常な哺乳動物のヘマトクリツト値の増大方法

1995
- 1995-09-14 DE DE19535571A patent/DE19535571A1/de not_active Withdrawn
1996
- 1996-09-12 NZ NZ319132A patent/NZ319132A/en not_active IP Right Cessation
- 1996-09-12 IL IL12364096A patent/IL123640A0/xx active IP Right Grant
- 1996-09-12 AT AT96932503T patent/ATE216256T1/de active
- 1996-09-12 MX MX9801922A patent/MX9801922A/es unknown
- 1996-09-12 HU HU9900357A patent/HU225363B1/hu unknown
- 1996-09-12 TR TR1998/00472T patent/TR199800472T1/xx unknown
- 1996-09-12 AU AU71282/96A patent/AU724623B2/en not_active Expired
- 1996-09-12 EP EP96932503A patent/EP0851762B1/de not_active Expired - Lifetime
- 1996-09-12 JP JP51166197A patent/JP4783482B2/ja not_active Expired - Lifetime
- 1996-09-12 DE DE59609099T patent/DE59609099D1/de not_active Expired - Lifetime
- 1996-09-12 KR KR10-1998-0701860A patent/KR100350761B1/ko not_active IP Right Cessation
- 1996-09-12 SK SK327-98A patent/SK285796B6/sk not_active IP Right Cessation
- 1996-09-12 ES ES96932503T patent/ES2174107T3/es not_active Expired - Lifetime
- 1996-09-12 CZ CZ1998726A patent/CZ291427B6/cs not_active IP Right Cessation
- 1996-09-12 BR BR9609971-2A patent/BR9609971A/pt not_active Application Discontinuation
- 1996-09-12 WO PCT/EP1996/003997 patent/WO1997009996A1/de active IP Right Grant
- 1996-09-12 US US09/029,859 patent/US6333306B1/en not_active Expired - Lifetime
- 1996-09-12 DK DK96932503T patent/DK0851762T3/da active
- 1996-09-12 PT PT96932503T patent/PT851762E/pt unknown
- 1996-09-12 PL PL96325640A patent/PL186776B1/pl unknown
- 1996-09-12 CN CNB961982845A patent/CN1133463C/zh not_active Expired - Lifetime
- 1996-09-12 DE DE19680768T patent/DE19680768D2/de not_active Expired - Lifetime
- 1996-09-12 EE EE9800066A patent/EE03856B1/et unknown
- 1996-09-12 CA CA002231192A patent/CA2231192C/en not_active Expired - Lifetime
- 1996-09-13 ZA ZA9607732A patent/ZA967732B/xx unknown
- 1996-12-09 UA UA98041874A patent/UA57713C2/uk unknown
1998
- 1998-03-11 IL IL123640A patent/IL123640A/en not_active IP Right Cessation
- 1998-03-13 NO NO19981136A patent/NO329908B1/no not_active IP Right Cessation
2001
- 2001-10-29 US US09/984,268 patent/US20020049161A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2174107T3 (es)	2002-11-01
CN1133463C (zh)	2004-01-07
UA57713C2 (uk)	2003-07-15
ATE216256T1 (de)	2002-05-15
NZ319132A (en)	1999-09-29
IL123640A (en)	2006-06-11
SK32798A3 (en)	1999-03-12
KR100350761B1 (ko)	2003-03-03
HUP9900357A2 (hu)	1999-05-28
DK0851762T3 (da)	2002-08-12
WO1997009996A1 (de)	1997-03-20
IL123640A0 (en)	1998-10-30
EE03856B1 (et)	2002-10-15
DE19535571A1 (de)	1997-03-20
AU7128296A (en)	1997-04-01
EP0851762A1 (de)	1998-07-08
CN1202113A (zh)	1998-12-16
ZA967732B (en)	1998-03-13
CA2231192C (en)	2003-02-25
US20020049161A1 (en)	2002-04-25
KR19990044610A (ko)	1999-06-25
JPH11512414A (ja)	1999-10-26
CA2231192A1 (en)	1997-03-20
HU225363B1 (en)	2006-10-28
MX9801922A (es)	1998-05-31
DE19680768D2 (de)	1998-11-05
HUP9900357A3 (en)	2001-04-28
PL186776B1 (pl)	2004-02-27
NO981136L (no)	1998-03-13
PL325640A1 (en)	1998-08-03
TR199800472T1 (xx)	1998-06-22
EE9800066A (et)	1998-08-17
DE59609099D1 (de)	2002-05-23
NO981136D0 (no)	1998-03-13
PT851762E (pt)	2002-08-30
AU724623B2 (en)	2000-09-28
CZ72698A3 (cs)	1998-07-15
JP4783482B2 (ja)	2011-09-28
BR9609971A (pt)	1999-09-14
US6333306B1 (en)	2001-12-25
NO329908B1 (no)	2011-01-24
EP0851762B1 (de)	2002-04-17
CZ291427B6 (cs)	2003-03-12

Publication	Publication Date	Title
SK285796B6 (sk)	2007-08-02	Farmaceutický prípravok na báze erytropoietínu a železa vo forme fyziologicky prijateľných zlúčenínželeza
US6372715B1 (en)	2002-04-16	Use of erythropoientin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
US6710028B2 (en)	2004-03-23	Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron
RU2188033C2 (ru)	2002-08-27	Комбинированные фармацевтические препараты, содержащие эритропоэтин и препараты железа
EP1085900B1 (en)	2009-06-10	Use of erythropoietin for the treatment of primary haemochromatoses
RU2173168C2 (ru)	2001-09-10	Фармацевтические комбинированные препараты, содержащие эритропоэтин и препараты железа
MXPA99008451A (en)	2000-06-01	Pharmaceutical combined preparations containing erythropoietin and iron preparations
CN1248920A (zh)	2000-03-29	含促红细胞生成素和铁制剂的药物联合制剂
KR20000076259A (ko)	2000-12-26	에리트로포이에틴과 철 제제를 포함하는 약학 조합제제
MXPA00001172A (en)	2001-05-17	The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
MXPA99011664A (en)	2000-06-01	Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins

Legal Events

Date	Code	Title	Description
2016-11-02	MK4A	Expiry of patent	Expiry date: 20160912